42
In band
Moving averages
SMA 200$22.11-71.14%
Company profile
Capricor Therapeutics, Inc., a biotechnology company, focuses on the development of transformative cell- and exosome-based therapies for the treatment and prevention of a broad spectrum of diseases. The company is headquartered in Beverly Hills, California.
SectorHealthcare
IndustryBiotechnology
Market cap$434.30M
P/E ratioNone
EPS$-2.57
Beta0.606
Dividend yield0.00%
52-week high$40.37
52-week low$2.96
Similar stocks in Biotechnology
BNTX
BioNTech SE
RSI 41
VRTX
Vertex Pharmaceuticals Inc
RSI 68
CRSP
CRISPR Therapeutics AG
RSI 48
IOVA
Iovance Biotherapeutics Inc
RSI 30
EDIT
Editas Medicine Inc
RSI 51
ALLO
Allogene Therapeutics Inc
RSI 29
ALT
Altimmune Inc
RSI 27
ARCT
Arcturus Therapeutics Holdings Inc
RSI 45
AGEN
Agenus Inc
RSI 47
ARTV
Artiva Biotherapeutics Inc
RSI 21
RSI alerts for CAPR
An email when CAPR closes below RSI 30 or above 70. Nothing else.
Add alertData last updated 13 October 2026 at 10:03 PM EDT